483
ENDO USA, Inc.FDA 483 - ENDO USA, Inc. - June 05, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of ENDO USA, Inc. in Rochester, MI, a biological drug manufacturer, revealed a significant issue with aseptic processing. Procedures designed to prevent microbiological contamination of sterile drug products were not followed. Specifically, operators were observed talking and moving hands in a fast, non-deliberate motion in Grade (b) (4) manufacturing areas during filling operations, indicating a breakdown in aseptic technique.
Open in Dashboard
ID · aaf10327-fc58-4ce7-9174-f165fd8d9972